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Abstract Personal genetic information has become
increasingly accessible to the public as a result of direct-to-
consumer (DTC) genetic tests; however, concerns have been
raised over their value and potential risks. We compared the
effects of providing genotype-based dietary advice with
general recommendations on behavioral outcomes using a
randomized controlled study. Participants were men and
women from the Toronto Nutrigenomics and Health Study
between the ages of 20–35 years (n = 149) who completed a
survey to assess their awareness of DTC genetic tests and
nutrigenomics, as well as potential motivations for under-
going genetic testing. Participants were then randomized
into an intervention (I) or control (C) group and were given
either genotype-based personalized dietary advice or general
dietary advice, respectively. A second survey was adminis-
tered to assess the participants’ opinions of the dietary
reports they received. A greater proportion of participants
in the intervention group agreed that they understood the
dietary advice they were given (93% (I) vs. 78% (C);
p = 0.009). Participants in the intervention group were more
likely to agree that the dietary recommendations they
received would be useful when considering their diet (88%
(I) vs. 72% (C); p = 0.02) and wanted to know more about
the recommendations (95% (I) vs. 76% (C); p \ 0.0001).
Only 9% of participants in the intervention group reported
feeling uneasy about learning their genetic information.
These findings suggest that individuals find dietary recom-
mendations based on genetics more understandable and
more useful than general dietary advice. Very few feel
uneasy about receiving their genetic information that relates
to personalized nutrition.
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Introduction
Recent advances in genomics technologies have made the
acquisition of personalized genetic information easily
obtainable. Direct-to-consumer (DTC) personal genetic
tests claim to provide consumers with information about
their genetic ancestry, ability to metabolize nutrients and
drugs, and risk for developing diseases (Janssens and van
Duijn 2010). One class of genetic tests offers personalized
dietary advice based on one’s DNA to improve health
(Sterling 2008). Nutrigenomics (or nutritional genomics) is
the study of the relationship between genes and diet, and is
used as an umbrella term for two complimentary approa-
ches: how nutrients affect gene function and how genetic
variation affects nutrient response (Cahill and El-Sohemy
2011). The latter is sometimes referred to as nutrigenetics
(El-Sohemy 2007) and includes the study of how genetic
variations affect food intake and eating behaviors (Eny and
El-Sohemy 2010; Garcia-Bailo et al. 2009). The DTC
method of marketing facilitates the sales of genetic tests
without the involvement of a healthcare professional
(Norrgard 2008). These tests are commercially available
through the Internet and are largely unregulated, though
significant measures are being taken to regulate this
emerging market in certain jurisdictions (McGuire et al.
2010). The cost of the different types of genetic tests
available can range from approximately $99 to over $2000
USD (Bloss et al. 2011a). DTC genetic testing for disease
D. E. Nielsen  A. El-Sohemy (&)
Department of Nutritional Sciences, Room 350,
University of Toronto, 150 College St, Toronto,
ON M5S 3E2, Canada
e-mail: a.el.sohemy@utoronto.ca
123
Genes Nutr (2012) 7:559–566
DOI 10.1007/s12263-012-0290-x
susceptibility remains controversial, with opponents arguing
that the tests possess limited value due to their questionable
clinical validity and utility (Burke 2009; Eng and Sharp
2010; Caulfield et al. 2010). Critics note that predicted risks
will continue to change as new genetic variants are discov-
ered, and thus any risk estimates for disease based on cur-
rently known common variants are premature (Janssens
et al. 2011; Mihaescu et al. 2009). Moreover, environmental
factors such as diet, smoking, and physical activity can have
a far greater impact on risk, but are often not considered
when providing estimates of risk. There is also concern that
consumers may experience anxiety if provided with the
estimates of higher risk for developing certain diseases
based on their genes and may seek out potentially unnec-
essary health interventions (McGuire and Burke 2008).
Another criticism of most DTC genetic tests is that the
corresponding advice is not genuinely personalized since the
lifestyle recommendations are generally the same, regard-
less of genotype. Despite these criticisms, proponents of
DTC genetic tests argue that there is public interest in
genomics and that individuals should have access to their
own genetic information (Bloss et al. 2011a; Caulfield et al.
2010). In addition, some propose that direct access to genetic
information may motivate consumers to adopt lifestyle
behavioral changes aimed at reducing the risk of disease
development (Bloss et al. 2011a; McBride et al. 2010).
Studies have reported different findings of the effects of
disclosure of genetic risk information on health-related
behaviors (Arkadianos et al. 2007; Chao et al. 2008; Conradt
et al. 2009; Lerman et al. 1997; Marteau et al. 2004;
McBride et al. 2002; Vernarelli et al. 2010); however, only
one study has investigated the impact of DTC genetic testing
on behavior and reported no short-term changes in specific
dietary or exercise behaviors (Bloss et al. 2011b). A limi-
tation of that study is that the genetic risk scores that were
given to the subjects were not specifically linked to a par-
ticular lifestyle behavior, and no personalized advice to
reduce the risk of developing a health condition was pro-
vided. Importantly, there was no control group in the study.
A recent survey of readers of the journal Nature shows that
27% of respondents who had their genomes analyzed
changed their diet, lifestyle, or medication based on their
genetic information, suggesting that genetic information
could impact behavior (Maher 2011).
For appropriate recommendations and regulations
regarding DTC genetic tests to be made, the public’s
knowledge and opinions of these technologies need to be
well understood. A number of studies have surveyed the
awareness of and attitudes toward DTC genetic tests either
among the general public or among healthcare providers
(Cherkas et al. 2010; Goddard et al. 2009; Stewart-Knox
et al. 2009; Gollust et al. 2011; Kolor et al. 2009; McGuire
et al. 2009; Taylor 2011; Goddard et al. 2007). These
studies report low awareness of genetic tests among the
general public (13–24%) (Cherkas et al. 2010; Goddard
et al. 2007, 2009), but higher awareness among healthcare
providers (42–44%) (Goddard et al. 2007; Kolor et al.
2009). Studies have reported an interest in genetic testing
among the public, with 50–66% of subjects reporting a
willingness to undergo testing (Cherkas et al. 2010;
McGuire et al. 2009; Stewart-Knox et al. 2009). Focus
group research has also been conducted to better under-
stand the knowledge and attitudes of consumers and
healthcare professionals toward nutrigenomics (Morin
2009; Weir et al. 2010). Most consumers in the focus
groups were unfamiliar with the term nutrigenomics and
did not relate the term personalized nutrition to an indi-
vidual’s genetic profile, whereas about half of healthcare
professionals were aware of the term nutrigenomics (Morin
2009). After being provided with an explanation of nutri-
genomics, consumers felt that a tailored diet could help
reduce the risk of disease development, while healthcare
professionals expressed more skepticism (Morin 2009).
While these studies provide valuable insight into the pub-
lic’s perceptions of nutrigenomics and genetic testing, they
have all been either observational or qualitative in design.
In addition, there has been some concern that genetic
information obtained from a DTC genetic test is not always
understood (Leighton et al. 2011), and no studies have
examined whether DTC genetic tests that provide person-
alized nutrition advice are understandable. The objectives
of the present study were to conduct a randomized con-
trolled trial to assess behavioral outcomes as well as the
awareness, perceptions, and understanding of nutrigenom-
ics and genetic testing.
Materials and methods
Study design and participants
The present study is a randomized controlled trial with a
2:1 ratio of participants in the intervention versus control
group. Ethics approval was obtained from the University
of Toronto Institutional Review Board, and the study
was registered with http://www.clinicaltrials.gov (NCT
01353014). Recruitment was carried out from May to
August 2011. Participants provided informed consent by
mail and then completed a baseline survey designed to
assess the awareness and opinions of genetic testing and
nutrigenomics using 4- and 5-point Likert scales. After the
baseline survey was completed, participants were ran-
domized to an intervention (I) or control (C) group using
Random Allocation Software.
Participants were recruited from the Toronto Nutrige-
nomics and Health Study (TNHS, n = 1,639), which is a
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cross-sectional study examining the role of genetics in food
intake and food selection as well as gene–diet interactions
on the biomarkers of chronic disease in young men and
women between the ages of 20–29 years at the time of
recruitment. The TNHS cohort is multi-ethnic, with par-
ticipants representing three major ethnic groups: Cauca-
sian, East Asian, and South Asian (Table 1). Recruitment
for the TNHS study was carried out at the University of
Toronto from 2004 to 2010. Participants provided a blood
sample, and genotyping was performed for several single
nucleotide polymorphisms (SNPs) involved in nutrient
response and metabolism. A subset of the TNHS cohort
(n = 354) was contacted by e-mail or phone to participate
in the present study (Fig. 1). Since the recommendations in
this study were based on caffeine, vitamin C, sugar, and
sodium, eligible participants were those who consumed at
least 100 mg of caffeine per day, 10% of total energy from
added sugars per day, and 1,500 mg of sodium per day and
did not take vitamin C-containing supplements. Three
e-mail attempts were made, and if no response was
received, one phone call was made. Eligible women who
were pregnant or breast-feeding at the time of recruitment
were excluded from the study.
Intervention
Participants in the intervention group (n = 92) were
e-mailed a personalized dietary report providing recom-
mendations for daily intakes of caffeine, vitamin C, sugar,
and sodium based on genotypes for CYP1A2 (Cornelis
et al. 2006; Palatini et al. 2009), GSTM1 and GSTT1
(Cahill et al. 2009; Horska et al. 2010), TAS1R2 (Eny et al.
2010), and ACE (Poch et al. 2001), respectively. The
reports were developed in collaboration with Nutrigenomix
Inc. (Toronto, Canada), which is a company that is
developing a nutrigenetics test kit for registered dietitians.
The reports provided participants with their genotype for
each gene, an explanation of what the genotype means in
terms of the dietary component and a personalized rec-
ommendation for daily intake of the dietary component
(Table 2). Participants in the control group (n = 46)
received general dietary recommendations from health
organizations for the same dietary components without
genetic information (Table 2). After participants read the
dietary report, a post-intervention survey was completed to
assess their opinions of the advice they were given.
Surveys
Surveys were created using the online survey site Survey-
Monkey (http://www.surveymonkey.com). Questions
included were based on a literature review as well as issues
raised in the Harvard University Personal Genetics Educa-
tion Project (Personal genetics education project 2010). The
baseline survey asked how much participants heard about
DTC genetic testing to assess their awareness (Table 3).
Participants were also asked how much they knew about
nutrigenomics. Survey statements such as ‘‘I would take a
genetic test to learn more about myself’’ were used to assess
participants’ motivations to undergo genetic testing
(Table 4). The post-intervention survey consisted of state-
ments such as ‘‘The dietary recommendations will be useful
when I consider my diet’’ to assess the participants’ opinions
of the value of the dietary recommendations (Fig. 2).
Table 1 Subject characteristics
Variable All subjects (n = 149) Intervention (n = 92) Control (n = 46) p-value
n (%)
Age (years)* 26 ± 4 27 ± 3 26 ± 3 0.82
Female 113 (76) 69 (75) 37 (80) 0.48
Ethnicity
Caucasian 92 (62) 59 (64) 24 (52) 0.18
East Asian 31 (21) 19 (21) 12 (26) 0.47
South Asian 16 (11) 9 (10) 6 (13) 0.56
Other 10 (7) 5 (5) 4 (9) 0.46
Education
Some college or undergraduate training 20 (13) 9 (10) 8 (17) 0.20
College or undergraduate degree 76 (51) 50 (54) 22 (48) 0.47
Graduate degree 53 (36) 33 (36) 16 (35) 0.90
The t test statistic was used to compare the age of subjects in the intervention versus control group
The Chi-square statistic was used to compare all other characteristics of subjects in the intervention versus control group
* Values shown are mean ± standard deviation
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Assessed for eligibility (n=1,639)
Excluded (n=1,482)
• Not meeting inclusion criteria (n=1,287)
• Less than 100 mg caffeine per day,
10% total energy from added sugars
per day, 1500 mg sodium per day, or
use of vitamin C containing
supplement (n=1,285)
• Pregnant (n=2)0
• Declined to participate (n=17)
• Unreachable by e-mail and phone (n=164)
• Expressed interest, but no response to
subsequent contact (n=14)
Analysed (n=46)





Sent baseline survey (n=157)
• Did not complete survey (n=8)
• Completed survey (n=149)
• Lost to follow-up (n=11)
• No response to subsequent contact (n=11)
Allocated to Intervention group 
(n=92)
Analysed (n=92)
Fig. 1 Consolidated standards of reporting trials (CONSORT) diagram of subject flow through the trial
Table 2 Sample of dietary advice for caffeine
Intervention
Health Canada’s recommendation for caffeine is at most 300 mg/day for women of child-bearing age and at most 400 mg/day for other
adults. Since you have the CC version of the CYP1A2 gene, you might benefit from limiting your caffeine intake to no more than 200 mg/
day. Caffeine is found in coffee, tea, cola beverages, and energy drinks. One small (8 oz) cup of coffee contains about 100 mg of
caffeine, while an 8 oz cup of tea contains about 50 mg of caffeine. One can (355 ml) of cola contains about 30 mg of caffeine, while the
caffeine content of energy drinks can range from 80 to 200 mg depending on the serving size and brand
Control
Health Canada’s recommendation for caffeine is at most 300 mg/day for women of child-bearing age and at most 400 mg/day for other
adults. Caffeine is found in coffee, tea, cola beverages, and energy drinks. One small (8 oz) cup of coffee contains about 100 mg of
caffeine, while an 8 oz cup of tea contains about 50 mg of caffeine. One can (355 ml) of cola contains about 30 mg of caffeine, while the
caffeine content of energy drinks can range from 80 to 200 mg depending on the serving size and brand
Table 3 Awareness of DTC genetic tests and nutrigenomics
Question Nothing A little bit A fair amount A lot
n (%)
How much have you heard about direct-to-consumer personal genetic tests?
(through media, friends, peers, etc.)
77 (52) 45 (30) 22 (15) 5 (3)
How much do you know about nutrigenomics or nutrigenetics? (the science
that examines the association between genes, nutrition, and health)
44 (30) 78 (52) 22 (15) 5 (3)
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Statistical analysis
Statistical analyses were performed using the Statistical
Analysis Software (version 9.2; SAS Institute Inc., Cary,
NC). Participants who reported ‘‘strongly agree’’ or
‘‘somewhat agree’’ to statements on the post-intervention
survey were grouped (‘‘agree’’), and the Chi-square test
was used to compare the frequency of ‘‘agree’’ to all other
responses (‘‘strongly disagree,’’ ‘‘somewhat disagree,’’ and
‘‘neither agree nor disagree’’). Fisher’s exact test was used
when a response category consisted of fewer than 5 counts.
Significant p values are two-sided and less than 0.05.
Results
Response rate and description of participants
Of the 157 participants who were sent the baseline survey,
149 participants completed the survey giving a response














I am interested in the relationship between diet and genetics 68 (46) 65 (44) 5 (3) 8 (5) 3 (2)
I would benefit from learning about how my genetic makeup affects my diet 99 (66) 32 (21) 10 (7) 4 (3) 4 (3)
Learning about my genetic makeup will affect what I eat 25 (17) 86 (58) 29 (19) 7 (5) 2 (1)
I am uncomfortable learning about my genetic makeup 11 (7) 11 (7) 13 (9) 22 (15) 92 (62)
I would take a genetic test to learn more about myself 72 (48) 56 (38) 14 (10) 5 (3) 2 (1)
I would take a genetic test to encourage myself to adopt a healthier lifestyle 67 (45) 57 (38) 13 (9) 8 (5) 4 (3)
I would take a genetic test to have my doctor monitor my health more closely 56 (38) 53 (35) 28 (19) 10 (7) 2 (1)
Fig. 2 Comparison of ‘‘agree’’
between intervention and
control group
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rate of 95% (Fig. 1). The mean ± standard deviation age
of the participants was 25 ± 4 years old and 76% were
female (Table 1). The participants were highly educated
with 87% having a university or college degree. Of the 149
participants who completed the baseline survey, 138 were
randomized into an intervention or control group. The
remaining 11 participants did not respond to subsequent
e-mail attempts. There were no significant differences
between the characteristics of participants in the control or
intervention group (Table 1).
Baseline survey
Approximately half of the participants (52%) reported
having heard ‘‘nothing’’ about DTC genetic testing, while
18% reported hearing ‘‘a fair amount’’ or ‘‘a lot’’. A smaller
proportion of participants reported knowing ‘‘nothing’’
about nutrigenomics (30%), with just over half reporting
that they knew ‘‘a little bit’’ about the science (52%)
(Table 3). Interest in the relationship between diet and
genetics was high, with 90% of participants reporting either
‘‘strongly agree’’ or ‘‘somewhat agree’’ to the survey
statement. The majority of participants (87%) also agreed
that they would benefit from learning about how their
genetic makeup would affect their diet. Consistent with
this, 75% of participants agreed that learning about their
genetic makeup would affect what they ate. The greatest
motivators participants reported for undergoing genetic
testing were to learn more about themselves and to
encourage themselves to adopt a healthier lifestyle (86 and
83%, respectively), while 73% of participants agreed that
they would take a genetic test to have their doctor monitor
their health more closely. Only 7% of participants strongly
agreed that they would be uncomfortable learning about
their genetic makeup (Table 4).
Post-intervention survey
After receiving the dietary report, a greater proportion of
participants in the intervention group agreed that they
understood the dietary advice they received (93% (I) vs.
78% (C); p = 0.009). As expected, more participants in the
intervention group agreed that the recommendations they
received were new to them (86% (I) vs. 28% (C);
p \ 0.0001). Participants in the intervention group were
also more likely to agree that they enjoyed learning about
the recommendations (96% (I) vs. 72% (C); p \ 0.0001),
and only 9% agreed that they felt uneasy learning about
their genetics (of which only one person reported ‘‘strongly
agree’’). In addition, participants in the intervention group
were more likely to agree that the recommendations would
be useful when considering their diet (88% (I) vs. 72% (C);
p = 0.02) and that they would like to know more about the
dietary recommendations they were given (95% (I) vs. 76%
(C); p \ 0.0001) (Fig. 2).
Discussion
The results of the present study demonstrate that individ-
uals are interested in nutrigenomics and report finding
dietary recommendations based on genetics more useful
than general dietary recommendations. Although concern
exists over the potential for genetic information to induce
anxiety in some individuals, very few participants in the
intervention group agreed that they felt uneasy learning
about their genetic information. Rather, 96% of partici-
pants who received their genetic information agreed that
they enjoyed learning about their genetic information and
dietary recommendations. This finding suggests that pro-
viding this kind of information is not likely to induce
anxiety and that young adults may embrace a new era of
personalized nutrition that could emerge through the
advancement of personalized genomics. However, the
nature of the genetic information that was provided in this
study might have been perceived as less serious than
genetic information related to disease risk. Although the
participants in this study had an awareness of the science of
nutrigenomics, only 18% reported an awareness of DTC
genetic testing while 52% reported no awareness. This
finding is consistent with previous surveys of the general
public conducted in the UK and US (Cherkas et al. 2010;
Goddard et al. 2007, 2009; Kolor et al. 2009). Despite the
considerable attention DTC genetic testing has received in
recent years (Lynch et al. 2011), this finding suggests that
media coverage of DTC genetic testing has not yet greatly
impacted young adults.
Scientific literacy and communication of genetic infor-
mation are important issues to consider when studying the
societal impact of DTC genetic testing (McBride et al.
2010). The literacy demands and quality of informational
content across DTC genetic testing Web sites have been
shown to vary (Lachance et al. 2010), and there is concern
that consumers may misinterpret or not understand DTC
genetic test results (Leighton et al. 2011). In the present
study, a greater proportion of participants in the interven-
tion group agreed that they understood the dietary report
they were given, suggesting that dietary recommendations
based on genetics can be more understandable than general
dietary recommendations. This implies that providing
individuals with clear, personalized nutritional advice may
result in greater understanding. An important strength of
the present study is the use of a randomized controlled trial,
which eliminates the possibility of confounding and allows
for direct comparisons to be made between experimental
groups.
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In considering the results of this study, some limitations
should be noted. In the present study, no in-person contact
was made with study participants, potentially affecting the
reliability of the results. However, DTC genetic testing can
be completed without in-person contact, so the nature of
this study closely mimics the nature of DTC genetic test-
ing. Seventy-six percent of participants in this study were
females, and this affected our ability to report any sex-
specific findings. However, excluding the males did not
materially alter any of the results, suggesting that there
were no major differences between men and women in this
population. The age of participants in the current study was
between 20 and 35 years, so findings might not be the
representative of other age groups. In addition, the partic-
ipants were highly educated and previously participated in
a nutrigenomics study. This could explain the high degree
of reported understanding of the gene-based dietary rec-
ommendations, although participants in the control group
reported less understanding of the general dietary recom-
mendations, yet were equally educated.
This study is the first to compare the impact of geno-
type-based personalized dietary advice with general dietary
recommendations. Dietary recommendations based on
genotype were reported to be more understandable than
general dietary recommendations and were also reported to
be more useful. Participants reported that they would not
be uncomfortable learning about their own genetic infor-
mation. Consistent with this, participants in the interven-
tion group did not express discomfort in learning about
their genetics and were more likely to report enjoyment in
learning about the dietary recommendations they were
given, as well as a greater desire to know more about the
recommendations. Direct-to-consumer genetic tests based
on personalized nutrition might, therefore, be more valu-
able that those based solely on disease risk predictions.
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